Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1997 May;121(2):187–192. doi: 10.1038/sj.bjp.0701118

NO-dependent and NO-independent IL-1 production by a human colonic epithelial cell line under inflammatory stress

Geneviève Vallette 1,*, Anne Jarry 1, Philippe Lemarre 1, Jean-Eric Branka 1, Christian L Laboisse 1
PMCID: PMC1564676  PMID: 9154326

Abstract

  1. The present study was designed to investigate, in an in vitro model of the human intestinal barrier, the ability of epithelial cells to produce interleukin-1 (IL-1), the cellular mechanisms involved in IL-1 release, and the intracellular signalling pathways involved in IL-1 up-regulation during inflammatory stress.

  2. This study was based on the human colonic epithelial cell line HT29-Cl.16E, maintained as polarized monolayers on filters mounted in culture chambers and treated with various proinflammatory cytokines (interferon γ (IFNγ), tumour necrosis factor α (TNFα), IL-1β) alone or in combination.

  3. IL-1 production, restricted to IL-1α, was induced by the combination of IFNγ/TNFα. When IL-1β was added to IFNγ/TNFα, it led to an additional production of IL-1α. IL-1α release was associated with cell damage, as shown by the correlation between lactate dehydrogenase (LDH) release and extracellular IL-1 production, and was not accounted for by a secretory mechanism.

  4. Both IFNγ/TNFα and IFNγ/TNFα/IL-1β induced inducible nitric oxide synthase (iNOS) expression as shown by quantitation of NO2/NO3 by use of the Griess reagent, quantitation of cells scoring positive with an anti-iNOS antibody and detection of mRNAs coding for iNOS by RT–PCR. The use of NG-monomethyl-L-arginine (L-NMMA), an inhibitor of NOS, led to the demonstration of two distinct signalling pathways in IL-1 production by HT29-Cl.16E cells, one dependent on NO (L-NMMA-sensitive) under treatment with IFNγ/TNFα/IL-1β, and the other independent of NO (L-NMMA-insensitive) under treatment with IFNγ/TNFα.

  5. Moreover, we examined whether a redox-based mechanism could be responsible for the apparent discrepancy between NO production and NO implication in IL-1 production under IFNγ/TNFα and IFNγ/TNFα/IL-1β treatments. Experiments with cysteine, which acts as a powerful reductant, suggest that the nitrosonium character of NO is involved in the NO-dependent pathway in IL-1 production.

Keywords: Human colonic epithelial cell line, inflammation, interleukin-1, cytokines, inducible nitric oxide synthase, nitric oxide, NG-monomethyl-L-arginine

Full Text

The Full Text of this article is available as a PDF (387.7 KB).


Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES